Guzman Y Gomez shares: Overvalued or still a buy?

Is the GYG valuation too spicy?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Guzman Y Gomez Ltd (ASX: GYG) share price has almost doubled from its initial public offering (IPO) price of $22 to today's $40, as the chart below shows. It's up 6.6% today, compared to a fall of 0.04% for the S&P/ASX 200 Index (ASX: XJO).

Guzman Y Gomez has delivered an amazing performance since listing on the ASX, considering some investors called its IPO share price 'expensive'.

But just because a valuation has been deemed high doesn't mean it can't continue to rise (significantly).

If an expensive company reports trading updates and results that are strong, it can justify its valuation. The financial numbers may even outperform the already-high expectations.

Let's look at what one expert thinks of the Mexican fast-food business.

A happy young woman in a red t-shirt hold up two delicious burritos.

Image source: Getty Images

UBS upgrades rating on Guzman Y Gomez shares

In a note this week to clients, UBS changed its rating on the business from sell to neutral. It also increased its 12-month price target from $37 to $40.

With the Guzman Y Gomez share price at $40.88 at the time of writing, the company has already exceeded the $40 price target.

The broker has increased its operating profit and earnings per share (EPS) estimates for FY25, FY26 and FY27 due to expectations of higher same-store sale (SSS) growth and stronger operating profit (EBITDA) margins.

With the potential for the company to achieve stronger earnings than expected, UBS suggests that "the risk-reward is more balanced despite the elevated" valuation multiple.

The broker said key drivers of GYG's SSS are menu innovation (including breakfast and coffee, and value offers), more sales in early and late times of the day and delivery growth.

UBS also said it remains "confident in the long-term potential for net new store growth" because of property team investment and attractive economics, with 15 new stores expected in the first half of FY25 and 31 guided for FY25.

In terms of the adjusted EBITDA to net margin, it's forecast to rise from 4.8% in FY24 to 6% in FY25 and 6.9% in FY26. UBS expects further margin expansion after FY26. UBS explained:

The key drivers of expansion are operating leverage (SSSg ahead of rental, labour & other costs; GYG having invested ahead of the curve [e.g. culinary & operations team]) and improving franchisor economics.

A question for GYG is how these tailwinds will be utilised; margin expansion vs redeployment back into the business (e.g. price, further investment).

Forecast for FY25

The broker projects that in the 2025 financial year, Guzman Y Gomez could generate $450 million in revenue, $30 million in earnings before interest and tax (EBIT), and $19 million in net profit.

In FY29, UBS forecasts GYG's revenue and net profit at $1.03 billion and $122 million, respectively. Time will tell if this helps the Guzman Y Gomez share price in the long term.

Motley Fool contributor Tristan Harrison has positions in Guzman Y Gomez. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Buy, hold, and sell ratings written on signs on a wooden pole.
Broker Notes

Up 59% in a year, should you still buy BHP shares today?

Three investment experts deliver their outlook for BHP shares.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, and holding a mobile phone in his other hand.
Broker Notes

Buy, hold, sell: CSL, QBE, and Pro Medicus shares

Let's see if analysts are bullish or bearish on these names.

Read more »

Excited couple celebrating success while looking at smartphone.
Broker Notes

Bell Potter names the best ASX shares to buy in April

What is the broker recommending to clients this month? Let's find out.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Broker Notes

Buy, hold, sell: Aristocrat, BHP, and Woodside shares 

Analysts have given their verdict on these shares. What are they saying?

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, South32, and Westpac shares

Analysts have given their verdict on these popular shares.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: ANZ, Breville, and Macquarie shares

Is Morgans bullish or bearish on these shares in April? Let's find out.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man sitting in a plane seat works on his laptop.
Broker Notes

Down 34% in 2026, are Virgin Australia shares a good buy today?

A leading analyst delivers his outlook for Virgin Australia’s beaten-down shares.

Read more »